May 14, 2020
Company Targets Anticipated EU Undersupply and Growing Opportunity
May 8, 2020
Timeline to first planting now measured in weeks
April 8, 2020
Partnership puts timeline in place for earned revenues
March 24, 2020
Isracann Biosciences (CSE:IPOT) is pleased to announce its entry into a joint venture agreement resulting in a phased partnership of...
February 27, 2020
Management undertakes extensive review of action plan, vendor activities and tour of regional land opportunities
January 9, 2020
Extensive report details project infrastructure advantages, efficiencies and opportunities from inception to production
January 2, 2020
Isracann Biosciences Inc. is pleased to announce entry into a Memorandum of Understanding towards a distribution agreement.